N@N

Market Maker Surveillance Report. CALI, CYCC, YGE, BVXV, NVCR, KPAY, Winning Stocks With Lowest Price Friction For Monday, Apr

^{Published on 2017-04-03 18:46:12 - WOPRAI}
 

April 3, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 5526 companies with "abnormal" market making, 2112 companies with positive Friction Factors and 3808 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. China Auto Logistics Inc. (NASDAQ:CALI), Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC), Yingli Green (NYSE:YGE), Biondvax Pharma Shs Sponsored American Depositary Share Repr Shs (NASDAQ:BVXV), NovoCure Limited (NASDAQ:NVCR), KinerjaPay Corp (OTC:KPAY). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  CALI    $0.330    0.22%     135,544      41.94%    122,990      38.05%    12,554       380     
  CYCC    $3.020    0.82%     4,416,031    35.97%    4,070,739    33.16%    345,292      1,143   
  YGE     $0.380    0.18%     276,312      43.54%    240,146      37.84%    36,166       952     
  BVXV    $1.000    0.17%     50,619       34.63%    47,376       32.41%    3,243        32      
  NVCR    $3.100    0.38%     8,537,428    36.48%    7,733,547    33.04%    803,881      2,593   
  KPAY    $0.810    0.45%     53,246       59.26%    36,018       40.09%    17,228       213     

For example, the chart above shows CALI with a dollar gain Monday of $0.33000 and a Friction Factor of 380 shares. That means that it only took 380 more shares of buying than selling to move CALI higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

China Auto Logistics Inc. (NASDAQ:CALI) - China Auto Logistics Inc. sells and trades in imported automobiles in the People s Republic of China. It operates through Sales of Automobiles, Financing Services, and Other Services segments. The company also offers financing services, including letter of credit issuance, purchase deposit financing, and import duty advances services, as well as automobile value-added services comprising customs clearance, storage, and delivery services. In addition, it provides Web-based advertising services through its Websites, such as at188.com that provides sales and trading information related to imported automobiles, as well as parts and components information; and at160.com, which offers price comparison, and sales and trading information. It primarily serves authorized dealers and agents, free traders or wholesalers, and individual customers. The company is headquartered in Tianjin, the People s Republic of China..

Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) - Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs for the treatment of cancer and other diseases. The company s oncology development programs include sapacitabine, a novel orally-available nucleoside analog that is in Phase III clinical trial for the front-line treatment of acute myeloid leukemia; in Phase II clinical trial for myelodysplastic syndromes; and in Phase I/II clinical trial in combination with seliciclib, a drug candidate to treat solid tumors. Its oncology development programs also comprise Seliciclib, an oral inhibitor of cyclin dependent kinase (CDK) 2/9 enzymes, which are central to the process of cell division and cell cycle control that has completed a Phase IIb clinical trial; and CYC065, a second generation CDK inhibitor, which is in Phase I clinical trial targeting CDK2/9 enzymes with potential utility in hematological malignancies and solid tumors. In addition, the company s oncology development programs include CYC140, a polo-like kinase inhibitor program that is in preclinical development stage; and Aurora Kinase inhibitors, a serine/threonine protein kinases that focuses on cell division or mitosis for the treatment of cancer. Cyclacel Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Berkeley Heights, New Jersey..

Yingli Green (NYSE:YGE) - Yingli Green Energy Holding Company Limited, together with its subsidiaries, designs, develops, markets, manufactures, sells, and installs photovoltaic (PV) products. The company offers polysilicon ingots and blocks, polysilicon wafers, PV cells, PV modules, and integrated PV systems; and develops and operates solar projects. It primarily sells its PV modules to distributors, wholesalers, power plant developers and operators, and PV system integrators under the brand names Yingli and Yingli Solar. The company operates primarily in the People s Republic of China, Japan, the United States, the United Kingdom, Chile, Algeria, Germany, France, South Africa, Turkey, and Honduras. Yingli Green Energy Holding Company Limited was founded in 1998 and is headquartered in Baoding, the People s Republic of China..

Biondvax Pharma Shs Sponsored American Depositary Share Repr Shs (NASDAQ:BVXV) - .

NovoCure Limited (NASDAQ:NVCR) - .

KinerjaPay Corp (OTC:KPAY) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net